Development goal: 15 generics a year

Rather than continuing to develop just a few generic pharmaceuticals a year, we are strengthening our R&D capabilities-in terms of personnel and research equipment-so that we might develop more than 15 generics a year.

With more some 150 items, Chemiphar boasts one of the largest line-ups of generic products (as of March 2010) of any Japanese innovative drug manufacturer.

Focusing on pharmaceuticals with expired patents and the biggest market share, Chemiphar has been involved in the development of such generics as the following :